Androgen Receptor Degradation (ARD) Enhancer

Posted in: News & Events
By Press Release
Jul 22, 2005 - 12:54:44 PM

Press Release

July 22, 2005 –AndroScience Corporation presented an abstract on the use of its novel Androgen Receptor Degradation (ARD) Enhancer in Acne and Alopecia at the American Academy of Dermatology Association Meeting on July 20-24, 2005 in Chicago. This represents a new class of drugs (ARD Enhancers) and the activity of these compounds in preclinical animal models. Using ARD-Enhancer as drug represents a potential breakthrough for the topical treatment of acne and alopecia, and is the first of its kind that works on the cause of the disease rather than treating the symptoms.


 
Home | Corporate Overview | Product Pipeline | Science & Technology | News & Events | Contact Us | Privacy Policy